Home > Healthcare > Medical Devices > Surgical Devices > interventional spine market
Get a free sample of Interventional Spine Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Interventional Spine Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The interventional spine industry is competitive in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products with improved efficiency and cost-effectiveness is among a key market strategy for interventional spine manufacturers. Some of the leading industry players including Alphatec Holdings, Inc, B. Braun Melsungen AG, Boston Scientific Corporation, ChoiceSpine LLC, and DePuy Synthes among others have a substantial presence in the market.
Some of the eminent market participants operating in the interventional spine industry include:
The global interventional spine market was valued at around USD 13.8 billion in 2023 and is expected to reach around USD 21.6 billion by 2032, driven by rising prevalence of spinal diseases, consistent technological advancements, and increasing demand for minimally invasive procedures.
The spinal fusion and fixation segment held majority revenue share in 2023 and is anticipated to reach USD 12.8 billion by 2032, owing to increased investment in healthcare infrastructure.
North America interventional spine industry accounted for USD 8 billion in 2023 and is predicted to witness significant growth over 2024 and 2032, backed by the development of advanced technologies and treatments models.
Alphatec Holdings, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, ChoiceSpine LLC, DePuy Synthes, Globus Medical, Inc., Integra LifeSciences Corporation, Medtronic plc, Nuvasive, Inc. and Orthofix Medical Inc.